Premier Alternatives

GC Therapeutics

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a genome-wide cell programming platform designed to convert patient-derived stem cells into multiple cell types. GC Therapeutics is based in Cambridge, MA and was founded in 2019. Its last known valuation is $135 million. It has raised $74.7 million.

Last price · $/share
—
Implied valuation
$135.0M
Total raised
$74.7M
Last round
—
What is GC Therapeutics worth?
$135.0Mlast known valuation
Free account
More of GC Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch GC Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GC Therapeutics funding history

No rounds on record

No funding rounds for GC Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

GC Therapeutics valuation

GC Therapeutics's last known valuation is $135 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How GC Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For GC Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about GC Therapeutics

What is GC Therapeutics worth?
GC Therapeutics's last known valuation is $135.0M.
How much has GC Therapeutics raised?
GC Therapeutics has raised $74.7M in total funding across its recorded rounds.